ASLN

ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN

Overview Fund Activity
Delisted

ASLN was delisted on the 18th of July, 2024.

Back to rankings

27 hedge funds and large institutions have $11.3M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
-4
Holders Change %
-12.9%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
6
Closed
5
Calls
$8K
Puts
$3K
Net Calls
+$5K
Net Calls Change
+$19K

Top Buyers

1
TCM
Tang Capital Management
California
$2.75M
2
Renaissance Technologies
Renaissance Technologies
New York
$236K
3
DCM
DAFNA Capital Management
California
$170K
4
Millennium Management
Millennium Management
New York
$804K
5
WW
Waterfront Wealth
Kansas
$175K

Top Sellers

1
MP
Mangrove Partners
Connecticut
$0
2
O
OrbiMed
New York
$0
3
Morgan Stanley
Morgan Stanley
New York
$127K
4
Bank of America
Bank of America
North Carolina
$44K
5
Citadel Advisors
Citadel Advisors
Florida
$1.33M
Name Holding Trade Value Shares
Change 		Shares
Change %
MP
26
Mangrove Partners
Connecticut
– -$1.75M -48,562 Closed
O
27
OrbiMed
New York
– -$1.75M -48,530 Closed
SCM
28
Silverarc Capital Management
Massachusetts
– -$1.59K -12,500 Closed
UBS Group
29
UBS Group
Switzerland
– -$6K -159 Closed
1
2